lswcap
Recently, medical advertisements without scientific basis have become a social problem. In response to this problem, Facebook has tried to prevent the spread of misinformation, and Amazon has shown a move to take countermeasures, such as removing a book from the site that says that drinking bleach can cure autism. Google also showed a new attitude to remove medical advertisements that have no scientific basis.
Google policy advisor Adrian Biddings unveiled an amendment to the blog advertising policy for Google ads posted on September 6. According to the new policy, Google is planning to ban advertisements about medical technologies, such as stem cell therapy and gene therapy, most of which are not proven or are in the experimental stage.
Recently, unlicensed stem cell clinics that have not been approved by the US Food and Drug Administration are expanding across the United States. It is a problem, such as receiving high medical expenses from patients, saying that it has realized a cancer vaccine optimized for individuals. Despite this move, Google has decided to exclude advertising about biomedical or unscientific based treatments.
Biddings points out that the treatments used for a wide range of patients require formal clinical trials, and treatments that are removed under the new policy lack basic scientific knowledge and preliminary clinical trials. This is the reason that malicious clinics use it for fraudulent practices for treatments that have not proven effective and safe through the correct process, and may not only attempt to gain personal benefit, but also pose health risks.
Google’s regulatory content is also approved by Deepak Srivastava, chairman of the International Society for Stem Cell Research, headquartered in the United States. Biddings added in a blog post that Srivastava said that stem cells have the potential to understand and treat a variety of diseases, but that many stem cell treatments are in the experimental stage and should only be provided in sufficiently regulated clinical trials.
Srivastava expressed concern that the commercial use of unproven stem cell treatments at an early stage could threaten public health and confidence in biomedical research and could adversely affect the development of legal treatments. Google also acknowledges the existence of excellent researchers in the field of stem cells, and says it will continue to accept announcements recruiting important clinical trial subjects in some countries. Related information can be found here .
Add comment